NCT06570941View on ClinicalTrials.gov

Benefits of a Cannabidiolic Acid Topical Cream for the Treatment of Restless Leg Syndrome

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

September 30, 2024

Study Completion Date

October 31, 2024

Conditions
Restless Legs Syndrome
Interventions
DRUG

Chylobinoid Topical Cream

The topical cream is applied to the effected area to reduce or eliminate the symptoms of restless leg syndrome

Trial Locations (1)

34238

Synthonics, Sarasota

All Listed Sponsors
lead

Synthonics Inc

INDUSTRY